Summary
This 2020 international multicentre study investigated whether sex-specific differences drive the distribution of molecular subtypes in muscle-invasive bladder cancer. The work, published in European Urology Oncology, examined a large cohort to characterise how molecular heterogeneity in MIBC varies between male and female patients, as suggested by the authorship and journal scope. The findings may inform sex-stratified approaches to molecular subtyping and treatment selection in bladder cancer.
UK applicability
The findings are relevant to UK urology and oncology practice, particularly in informing personalised medicine approaches to MIBC across NHS cancer services. UK bladder cancer centres may use these insights to improve molecular subtyping and sex-informed treatment stratification.
Key measures
Molecular subtype classification; sex-stratified prevalence; association between sex and molecular subtype distribution
Outcomes reported
The study examined the distribution of molecular subtypes in muscle-invasive bladder cancer (MIBC) across a large patient cohort and analysed whether sex differences drive variation in molecular subtype prevalence.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.